Abstract: An amendment to this paper has been published and can be accessed via a link at the top of the paper. This correction addresses critical errors in the histological data originally presented to validate a novel photoacoustic imaging technique for heart disease.
Introduction: The Challenge of MI Detection
The original research focuses on the challenge of non-invasively detecting Coronary Artery Disease (CAD) and Myocardial Infarction (MI). Standard diagnostics often lack the resolution or molecular specificity to distinguish between healthy and scarred heart tissue in real-time. The authors proposed using erythrocyte-derived optical nanoparticles (NETs) as a contrast agent for photoacoustic imaging.
The Role of Histological Validation
This correction is vital because histology is the "gold standard" used to prove that the areas highlighted by the new imaging technique actually correspond to physical tissue damage (infarction) or healthy muscle. The corrected figures provide the necessary visual evidence to support the study's claims.
In the Trichrome staining shown above, the technique differentiates between muscle and connective tissue. Specifically, it identifies collagen fibers (stained blue), which indicate scarring and necrosis in the infarct region, versus viable myocytes (stained red).
Key Pathological Insights
The researchers used a common mouse model of MI where the Left Anterior Descending (LAD) coronary artery is surgically tied off (ligated) to induce a heart attack. The corrected Figure 1 (replacing the original Figure 7) provides several critical observations:
- Visualizing the Infarct: The corrected Trichrome stains clearly show the "blue" collagenous scar tissue in the left ventricle, contrasting sharply with the "bright red" healthy muscle of the right ventricle.
- Early Thrombus Detection: Panel (d) identifies an early thrombus (blood clot), marked with a yellow arrow. This is a critical pathological feature that validates the model's relevance to human CAD.
- Anatomical Accuracy: The corrected legend accurately identifies the green arrow as the ligated LAD coronary artery and the black arrow as the surrounding infarct area.
Safety and Biocompatibility
Beyond the heart, the study examined systemic safety using H&E (Hematoxylin and Eosin) Staining. This standard safety check ensures the nanoparticles do not cause inflammation, fibrosis, or necrosis in off-target organs. As seen in panel (f) of the corrected figure, the H&E staining of the liver shows a normal portal tract and parenchyma, suggesting that the erythrocyte-derived nanoparticles are biocompatible and do not trigger an adverse immune response.
Conclusion
By providing these corrected panels, the authors reinforce the claim that their photoacoustic imaging correlates with the physical presence of blue-stained collagen (scarring) and the absence of red-stained viable muscle. This correction ensures the published record accurately reflects the experimental results obtained during the original study, confirming the potential of NETs as a safe and effective imaging agent for cardiovascular disease.
Summary updated